PMDS is on track to reach positive cash flow by the year-end 2024, and the company will repeat its t...
Redeye provides its initial take on Navigo’s Q2 2024 report, which came in just slightly below our e...
Redeye’s first comments on the Q2 report this morning.
Redeye views Acarix's Q2 as weaker than anticipated, with lower-than-expected revenues.
STENOCARE published on August 21st the company’s Q2-report for 2024.
Redeye stated that Gapwaves’ Q2 2024 report exceeded its, and consensus expectations.
Redeye sees a mixed Q2 report from BrightBid, with slow q/q cARR growth as the weak spot and solid c...
Redeye states that the Q2 report came in weaker than expected, with both sales and costs surprising ...
Redeye saw a Q2 report in which sales and gross margins did not deviate much from our expectations, ...
Redeye remains cautious about Payday 3's comeback. While increased player activity following new con...
Redeye provides an update on Thunderful Group following its Q2 2024 report.
Zoomability Int AB (”Zoomability” eller ”bolaget”) publicerade den 21 augusti 2024 bolagets delårsra...
Omsättningen minskade under kvartalet och höga nedskrivningar pressar rörelseresultatet.
Arctic Blue Beverages har publicerat bolagets delårsrapport för det andra kvartalet år 2024.
Redeye is encouraged to see AroCell recording its first quarter with a positive cash flow, and the r...
